Market-Access-Commercial

Matching platforms and contract manufacturers that connect biotech companies needing fermentation capacity with idle or available bioreactor capacity, easing the scale-up bottleneck between lab-scale precision fermentation and commercial-volume production.

Contract development, technology-transfer and local-build services that establish in-country or regional biomanufacturing so a biologic or vaccine qualifies for market access, procurement preference and supply security in target jurisdictions.

Regulated pre-approval access to investigational biopharmaceuticals for patients with serious or life-threatening disease and no satisfactory alternative — operated as a managed-access service spanning eligibility, regulatory submission, GMP drug sourcing and pharmacovigilance.